IRVINE, Calif.--(BUSINESS WIRE)--Cobalis Corp. (OTC BB: CLSC), a pharmaceutical development company specializing in anti-allergy medications, announced today it is scheduled to present at the Rodman & Renshaw 8th Annual Healthcare Conference on Tuesday, November 7, 2006. Cobalis Chief Executive Officer Jerry Yakatan, PhD., will address the investment community that morning at approximately 10:35 a.m. ET at the New York Palace Hotel in New York City.
